ArticleFrontiers in oncology2024

Improved survival with second-line hepatic arterial infusion chemotherapy after atezolizumab-bevacizumab failure in hepatocellular carcinoma.

Ji Yeon Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.